HYALURONIDASE

Product NDC
51662-1555
11-digit product format
516621555
Labeler code
51662
Product ID
51662-1555_c3f1db01-58c0-2226-e053-2a95a90a8b33
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
HYALURONIDASE
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Labeler
HF Acquisition Co LLC, DBA HealthFirst
Application
BLA021859
Marketing category
BLA
Marketing start
2021-06-04
Substance
HYALURONIDASE (HUMAN RECOMBINANT)
Active strength
150 [USP'U]/mL
Pharmacologic classes
Endoglycosidase [EPC], Glycoside Hydrolases [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
HYALURONIDASE
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
HYALURONIDASE (HUMAN RECOMBINANT)150 [USP'U]/mL

Harmonized Identifiers#

Field, Values table
FieldValues
Unii743QUY4VD8
Rxcui630936, 630939

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fba5a780-b52d-4964-b662-1526b044aec4Product name120260127
64196b0b-840e-435b-8afa-0b0e9d9cea99Product name120251024
4b151d8d-9b47-43df-bccb-6abc1c4e7194Product name120250331
d745a796-f789-46a3-afa3-79dead22a863Product name120250331
00bb4496-246c-4f2c-910a-2b2783035958Product name120231025
bd11614e-4776-4a92-aaca-2bcbb5f710edProduct name120210115
0c6eff6a-9a1e-468b-b9ca-6bc864c2e8cbProduct name120200925
6d78c268-2e9d-bd45-9f2d-965fd0e582caProduct name220200323
980b5d64-e8e5-e1c9-b721-75e08f4e00a1Product name220200323
b914e981-d6dc-4748-bd51-accd6b85b817Product name120190618
4597a7a9-59c8-4eb4-b516-4f26fa3dfe4bProduct name120170804
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51662-1555-1HYALURONIDASE1 mL in 1 VIALINJECTION, SOLUTION11
51662-1555-1HYALURONIDASE1 in 1 BOXINJECTION, SOLUTION11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51662-1555HYALURONIDASE INJECTION, SOLUTION [HF ACQUISITION CO LLC, DBA HEALTHFIRST]1Current NDC, Legacy NDC, 2 package rows20210606_c3f1db01-58bf-2226-e053-2a95a90a8b33.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
630936hyaluronidase, human recombinant 150 UNT in 1 ML InjectionPSNc3f1db01-58bf-2226-e053-2a95a90a8b331
630939Hylenex 150 UNT in 1 ML InjectionPSNc3f1db01-58bf-2226-e053-2a95a90a8b331
6309391 ML hyaluronidase, human recombinant 150 UNT/ML Injection [Hylenex]SBDc3f1db01-58bf-2226-e053-2a95a90a8b331
6309361 ML hyaluronidase, human recombinant 150 UNT/ML InjectionSCDc3f1db01-58bf-2226-e053-2a95a90a8b331
630936hyaluronidase, human recombinant 150 UNT per 1 ML InjectionSYc3f1db01-58bf-2226-e053-2a95a90a8b331
630939Hylenex 150 UNT per 1 ML InjectionSYc3f1db01-58bf-2226-e053-2a95a90a8b331

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
51662-1555-1516621555011 VIAL in 1 BOX (51662-1555-1) / 1 mL in 1 VIAL1 vial2021-06-040000-00-00NoNoCurrent